We are looking for 2–17 year olds to join a clinical trial to help us discover more about treating moderately to severely active ulcerative colitis. If you are looking for a potential new treatment option for moderately to severely active ulcerative colitis or moderate to severe IBD (including associated symptoms such as diarrhea with blood, weight loss, abdominal pain, weight loss and/or joint pain), consider one of our IBD clinical trials. All eligible participants will receive no-cost study-related care and study medication. Your 2–17 years old may be eligible to take part.
Your child may be eligible to take part in the IBD clinical trials if they:
- are 2‒17 years of age
- have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
- have previously received treatment for UC or CD that has not worked.
Find out if your child may be able to take part.
